2020
DOI: 10.33320/maced.pharm.bull.2020.66.03.007
|View full text |Cite
|
Sign up to set email alerts
|

Regulatory status of nutraceuticals – is it rationale to rethink?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 3 publications
0
0
0
Order By: Relevance